diarrhea while on glp 1 tirzepatide (Mounjaro) affects approximately 23–31% of patients and is typically mild to moderate, transient, and most common during dose escalation. , It rarely requires discontinuation Can GLP-1 Cause Diarrhea? What

Follow-up investigations should continue to explore the role brain GSH and other central markers of oxidative stress might have in PTSD

Retrieved 4 October 2025

Looking Ahead As Wegovys removal from the shortage list becomes official, expect: Heavy Crackdown on Compounders: Manufacturers and regulators will likely move quickly to shut down operations found selling compounded forms that mimic FDA-approved products

Patterns will emerge

Liu S, Liu T, Li J, Hong J, Moosavi-Movahedi AA, Wei J (2025) Type 2 Diabetes Mellitus Exacerbates Pathological Processes of Parkinsons Disease: Insights from Signaling Pathways Mediated by Insulin Receptors